AMANDA BAXTER: Open Payments
NPI 1346533163 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 24 payments from 12 companies in 2025. Trend: 2023 $468 · 2024 $348 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $77 |
| Boston Scientific Corporation | 2 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| SCPHARMACEUTICALS INC. | 3 | $58 |
| Amgen Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
Products named: WATCHMAN, JARDIANCE, FUROSCIX, REPATHA, Wegovy, LEQVIO, VERQUVO, Kerendia.
Industry payments across NY — which companies pay providers there.
